FDA inspection
Galephar Pharmaceutical Research Inc.: FDA inspection ending Jun 5, 2025
FDA inspection 1273815 · No Action Indicated (NAI) · Humacao, PR
Key facts
| Inspection ID | 1273815 |
|---|---|
| Firm | Galephar Pharmaceutical Research Inc. |
| FEI number | 3008206797 |
| Address | Rd 925 Km 6.1 Bo Junquito |
| City | Humacao |
| State | PR |
| ZIP | 00741 |
| Country | United States |
| Fiscal year | 2025 |
| Inspection end date | Jun 5, 2025 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data